Modifier genetics in zebrafish identify Chk1 and an associated survival pathway as targets for pharmacotherapy of MDS/AML with P53 mutations.

Samuel Sidi, Andreas T. Hagen, Richard Kennedy, Shintaro Imamura, Shuji Kishi, John Kanki, Alan D'Andrea, A. Thomas Look

Research output: Contribution to journalMeeting abstract

Original languageEnglish
Pages (from-to)416A-416A
Number of pages1
JournalBlood
Volume108
Issue number11
Publication statusPublished - 16 Nov 2006
Event48th Annual Meeting of the American-Society-of-Hematology - Orlando, United States
Duration: 09 Dec 200612 Dec 2006

Cite this

Sidi, S., Hagen, A. T., Kennedy, R., Imamura, S., Kishi, S., Kanki, J., D'Andrea, A., & Look, A. T. (2006). Modifier genetics in zebrafish identify Chk1 and an associated survival pathway as targets for pharmacotherapy of MDS/AML with P53 mutations. Blood, 108(11), 416A-416A.